Cancer: Calculated treatment

Nature

Volumn 499, Issue 7458, 2013, Pages 291-292

  Komarova, Natalia L ^a   Boland, C Richard ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMATINIB;

CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER RESISTANCE; CANCER SIZE; CANCER SURVIVAL; CELL DEATH; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CROSS RESISTANCE; DRUG MECHANISM; HUMAN; IN VITRO STUDY; MATHEMATICAL MODEL; MELANOMA; MONOTHERAPY; MYELOID LEUKEMIA; NOTE; PANCREAS CANCER; PATIENT CODING; PERSONALIZED MEDICINE; PLASTICITY; PRIORITY JOURNAL; SKIN CANCER;

EID: 84880411197     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/499291a     Document Type: Note

References (8)

1. Bozic, I. et al. eLIFE 2, e00747 (2013).
2. Zhang, J., Yang, P. L. & Gray, N. S. Nature Rev. Cancer 9, 28-39 (2009).
3. Diaz, L. A. Jr et al. Nature 486, 537-540 (2012).
4. Katouli, A. A. & Komarova, N. L. Bull. Math. Biol. 73, 549-584 (2011).
5. Komarova, N. L. & Wodarz, D. Proc. Natl Acad. Sci. USA 102, 9714-9719 (2005).
6. Komarova, N. L., Katouli, A. A. & Wodarz, D. PLoS ONE 4, e4423 (2009).
7. Bradeen, H. A. et al. Blood 108, 2332-2338 (2006).
8. Katouli, A. A. & Komarova, N. L. PLoS ONE 5, e12300 (2010).